Therefore, attenuation of angiotensin II and TGF-β, in addition to the reduction in MMP-9 by chymase inhibition, might contribute to preventing and improving NASH. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatohepatitis.